申请人:Adir et Compagnie
公开号:US05276051A1
公开(公告)日:1994-01-04
The invention relates to a compound selected from those of formula (I): ##STR1## in which Ar', R.sub.1 and R.sub.2 are as defined in the specification, an optical isomer, and an addition salt thereof with a pharmaceutically-acceptable acid or base. Medicinal product which is useful in treating or in preventing a disorder of the melatoninergic system.
该发明涉及一种从以下化合物中选择的化合物(I):##STR1##其中Ar'、R1和R2如规范中所定义,光学异构体,以及其与药用可接受酸或碱的加合盐。用于治疗或预防褪黑素系统紊乱的药物产品。